These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10026385)

  • 1. The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships.
    Nagy Z; Hindley NJ; Braak H; Braak E; Yilmazer-Hanke DM; Schultz C; Barnetson L; King EM; Jobst KA; Smith AD
    Dement Geriatr Cogn Disord; 1999; 10(2):115-20. PubMed ID: 10026385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study.
    Nagy Z; Hindley NJ; Braak H; Braak E; Yilmazer-Hanke DM; Schultz C; Barnetson L; Jobst KA; Smith AD
    Dement Geriatr Cogn Disord; 1999; 10(2):109-14. PubMed ID: 10026384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms increase the likelihood of cognitive impairment in elderly people with subclinical Alzheimer pathology.
    Milwain EJ; Nagy Z
    Dement Geriatr Cogn Disord; 2005; 19(1):46-50. PubMed ID: 15383746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease.
    Gastard MC; Troncoso JC; Koliatsos VE
    Ann Neurol; 2003 Sep; 54(3):393-8. PubMed ID: 12953274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease.
    Stein DJ; Buchsbaum MS; Hof PR; Siegel BV; Shihabuddin L
    Neuropsychobiology; 1998; 37(1):10-9. PubMed ID: 9438267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologic substrate of mild cognitive impairment.
    Markesbery WR; Schmitt FA; Kryscio RJ; Davis DG; Smith CD; Wekstein DR
    Arch Neurol; 2006 Jan; 63(1):38-46. PubMed ID: 16401735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old age.
    van der Flier WM; Middelkoop HA; Weverling-Rijnsburger AW; Admiraal-Behloul F; Bollen EL; Westendorp RG; van Buchem MA
    Dement Geriatr Cogn Disord; 2005; 20(2-3):82-8. PubMed ID: 15942197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cued recall measure predicts the progression of gray matter atrophy in patients with amnesic mild cognitive impairment.
    Koric L; Ranjeva JP; Felician O; Guye M; de Anna F; Soulier E; Didic M; Ceccaldi M
    Dement Geriatr Cogn Disord; 2013; 36(3-4):197-210. PubMed ID: 23899504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography.
    Jobst KA; Smith AD; Szatmari M; Molyneux A; Esiri ME; King E; Smith A; Jaskowski A; McDonald B; Wald N
    Lancet; 1992 Nov; 340(8829):1179-83. PubMed ID: 1359259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease.
    Jobst KA; Smith AD; Szatmari M; Esiri MM; Jaskowski A; Hindley N; McDonald B; Molyneux AJ
    Lancet; 1994 Apr; 343(8901):829-30. PubMed ID: 7908080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant progression in parietal-dominant atrophy subtype of Alzheimer's disease occurs independent of onset age.
    Na HK; Kang DR; Kim S; Seo SW; Heilman KM; Noh Y; Na DL
    Neurobiol Aging; 2016 Nov; 47():149-156. PubMed ID: 27592283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes.
    de Ávila C; Suazo C; Nolz J; Nicholas Cochran J; Wang Q; Velazquez R; Dammer E; Readhead B; Mastroeni D
    Neurobiol Aging; 2024 Sep; 141():160-170. PubMed ID: 38964013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological correlates of cognitive decline in Alzheimer's disease.
    Thind K; Sabbagh MN
    Panminerva Med; 2007 Dec; 49(4):191-5. PubMed ID: 18091671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity.
    Fujino Y; Delucia MW; Davies P; Dickson DW
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):676-82. PubMed ID: 15541007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senile dementia of Alzheimer type characterized by laminar neuronal loss exclusively in the hippocampus, parahippocampus and medial occipitotemporal cortex.
    Mizutani T; Amano N; Sasaki H; Morimatsu Y; Mori H; Yoshimura M; Yamanouchi H; Hayakawa K; Shimada H
    Acta Neuropathol; 1990; 80(6):575-80. PubMed ID: 2275334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.